RESMED INC (RMD) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:RMD • US7611521078
RMD Key Statistics, Chart & Performance
The current stock price of RMD is 271.63 USD. In the past month the price increased by 8.25%. In the past year, price increased by 14.64%.
RMD Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to RMD. When comparing the yearly performance of all stocks, RMD turns out to be only a medium performer in the overall market: it outperformed 67.09% of all stocks.
RMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to RMD. RMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
RMD Financial Highlights
Over the last trailing twelve months RMD reported a non-GAAP Earnings per Share(EPS) of 10.28. The EPS increased by 16.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.53% | ||
| ROA | 17.47% | ||
| ROE | 23.51% | ||
| Debt/Equity | 0.06 |
RMD Forecast & Estimates
25 analysts have analysed RMD and the average price target is 303.52 USD. This implies a price increase of 11.74% is expected in the next year compared to the current price of 271.63.
For the next year, analysts expect an EPS growth of 16.4% and a revenue growth 10.01% for RMD
RMD Ownership
RMD Latest News, Press Relases and Analysis
RMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.33 | 189.676B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.14 | 168.855B | ||
| SYK | STRYKER CORP | 23.7 | 138.597B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 115.097B | ||
| BDX | BECTON DICKINSON AND CO | 13.98 | 58.942B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.391B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.59 | 45.321B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 37.494B | ||
| DXCM | DEXCOM INC | 27.8 | 27.258B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RMD
Company Profile
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company Info
RESMED INC
9001 Spectrum Center Blvd
San Diego CALIFORNIA 92123 US
CEO: MichaelJ.Farrell
Employees: 9980
Phone: 18587462400
RESMED INC / RMD FAQ
What does RESMED INC do?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Can you provide the latest stock price for RESMED INC?
The current stock price of RMD is 271.63 USD. The price increased by 1.72% in the last trading session.
Does RMD stock pay dividends?
RESMED INC (RMD) has a dividend yield of 0.9%. The yearly dividend amount is currently 2.12.
What is the ChartMill rating of RESMED INC stock?
RMD has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the analyst forecast for RMD stock?
25 analysts have analysed RMD and the average price target is 303.52 USD. This implies a price increase of 11.74% is expected in the next year compared to the current price of 271.63.
How many employees does RESMED INC have?
RESMED INC (RMD) currently has 9980 employees.
When does RESMED INC (RMD) report earnings?
RESMED INC (RMD) will report earnings on 2026-04-21.